Does AngioDynamics (ANGO) Have the Potential to Rally 92.15% as Wall Street Analysts Expect?

Core Viewpoint - AngioDynamics (ANGO) shares have shown a slight increase of 0.1% over the past four weeks, closing at $10.06, with analysts suggesting a potential upside of 92.2% based on a mean price target of $19.33 [1] Price Targets and Analyst Consensus - The average price target for ANGO ranges from a low of $16.00 to a high of $24.00, with a standard deviation of $4.16, indicating a potential increase of 59.1% to 138.6% from the current price [2] - A low standard deviation suggests a strong agreement among analysts regarding the price targets, which can be a positive indicator for investors [2][9] Earnings Estimates and Analyst Optimism - Analysts have shown increasing optimism about ANGO's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 3.6% over the past month, with no negative revisions, indicating positive sentiment [12] Zacks Rank and Investment Potential - ANGO holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential for upside in the near term [13]